增高机构自曝敛财真相：靠玄学，不来我们这里，孩子也会长的

Core Viewpoint - The article highlights the prevalence of fraudulent height-increasing services targeting children, with multiple companies making misleading claims about their effectiveness and safety [1][7][10]. Group 1: Company Practices - Various businesses, such as "安立身青少年物理增高" and "德脊瑞青少年物理增高," are promoting height-increasing treatments with promises of refunds if results are not achieved [3][7]. - The "安立身" company claims that children will grow regardless of their services, but does not disclose this to parents [5][10]. - "德脊瑞" claims to have unique technology for height increase, but the equipment's actual function is unrelated to height growth, focusing instead on inflammation and pain relief [9][10]. Group 2: Misleading Claims - The "德脊瑞" company has been found to misrepresent its patents, which do not support claims of stimulating bone growth [9][10]. - Another company, "英瑞可," makes scientifically unfounded claims about increasing height in individuals with closed growth plates, stating they can provide various treatments without any medical validation [10][12]. Group 3: Company Backgrounds - "安立身健康管理有限公司" was established in April 2024 with a registered capital of 1 million RMB, focusing on health consulting and management services [12][13]. - "苏州英瑞可健康管理有限公司" was founded in September 2024 with a registered capital of 500,000 RMB, also offering health consulting and management services [15][17]. Group 4: Industry Overview - As of now, there are over 17.19 million healthcare-related enterprises in China, with Guangdong, Shandong, and Henan leading in numbers [19]. - Among healthcare businesses, 1.37% have faced legal disputes, 3.57% have experienced operational anomalies, and 1.13% have been subject to administrative penalties [19].